HIPAA SECURE
Reorder Refill (657) 837-3342
Already a patient? You have already been evaluated, no need to requalify and no new $119 consultation fee. Reorder your refill →

Medical Questionnaire

Pre-qualification for physician consultation, takes about 3 minutes

Step 1: Contra-Indicated Conditions

Please check all that apply. These conditions prevent treatment with GLP-1 medications.

Step 2: Additional Health History

Check all that apply. This information will be reviewed by our physician to ensure safe, personalized treatment.

Step 3: Your Contact Information

Almost done. Confirm your contact details and add your shipping address. For your privacy, the quiz and this medical form are stored separately, so we ask again here.

Telehealth service is available for eligible California patients. For other locations, availability depends on licensure and separate dispensing-pharmacy confirmation.

Next step after you submit: secure checkout for your one-time $119 physician review. Medication is separate (compounded semaglutide from $166/mo, tirzepatide from $233/mo) and is only charged if the physician prescribes it for you. Compounded medications are not FDA-approved and not brand-identical; results vary. HSA/FSA accepted; Cherry, Klarna, and Affirm financing available. See payment options.

By submitting, you agree to our Privacy Policy and HIPAA Notice, and consent to be contacted by our medical team.

HIPAA Protected  |  256-bit SSL Encrypted

Questionnaire Submitted!

Your medical questionnaire has been submitted for physician review. Continue to secure checkout to complete your one-time $119 physician review. Medication is separate and is only charged if prescribed.

Redirecting to secure checkout for your $119 review in 3...

Continue to Payment →

Return Home

Questions? Call (657) 837-3342

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.